Insider Trading History of Stejbach Mark

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Stejbach Mark since 2010. The trader's CIK number is 1487937. At the time of the last reporting, Stejbach Mark was the VP & Chief Commercial Officer of Flexion Therapeutics Inc. (stock ticker symbol FLXN). Also see all insider trading activities at Flexion Therapeutics Inc.

Note that in the past Stejbach Mark also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Flexion Therapeutics Inc (FLXN) by Stejbach Mark

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 FLXN 2,051 $19,997 0 $0 0 $0
2017 FLXN 1,580 $26,888 0 $0 0 $0

Yearly summary of insider trading at Alkermes Plc. (ALKS) by Stejbach Mark

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 ALKS 0 $0 10,880 $767,094 24,568 $188,224
2017 ALKS 0 $0 20,000 $1,204,005 33,187 $345,999
2016 ALKS 0 $0 0 $0 16,093 $99,994
2015 ALKS 0 $0 46,000 $3,414,928 57,092 $895,794
2014 ALKS 0 $0 0 $0 5,280 $48,094
2013 ALKS 0 $0 0 $0 3,000 $51,900
2012 ALKS 1,200 $24,156 0 $0 0 $0

Yearly summary of insider trading at Tengion Inc (TNGN) by Stejbach Mark

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 TNGN 100 $500 0 $0 0 $0


Insider trading activities at 3 companies by Stejbach Mark:

1. Flexion Therapeutics Inc (FLXN)

2. Alkermes Plc. (ALKS)

3. Tengion Inc (TNGN)

Table 1. Insider trading of Flexion Therapeutics Inc (FLXN) by Stejbach Mark

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-05-26 FLXN Buy 2,051 9.75 19,997
2017-06-16 FLXN Buy 1,580 17.02 26,888

Table 2. Insider trading of Alkermes Plc. (ALKS) by Stejbach Mark

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-03-01 ALKS Option Ex 5,250 .00 0
2018-03-03 ALKS Option Ex 2,813 .00 0
2018-02-26 ALKS Option Ex 2,625 .00 0
2018-02-16 ALKS Sale 10,880 70.50 767,094
2018-02-17 ALKS Option Ex 3,000 .00 0
2018-02-16 ALKS Option Ex 10,880 17.30 188,224
2017-06-08 ALKS Sale 10,000 60.34 603,350
2017-06-08 ALKS Option Ex 10,000 17.30 173,000
2017-05-28 ALKS Option Ex 2,500 .00 0
2017-03-03 ALKS Option Ex 2,812 .00 0
2017-03-01 ALKS Option Ex 5,250 .00 0
2017-02-26 ALKS Option Ex 2,625 .00 0
2017-01-09 ALKS Option Ex 547 17.30 9,463
2017-01-09 ALKS Sale 547 60.27 32,967
2017-01-04 ALKS Option Ex 2,500 17.30 43,250
2017-01-05 ALKS Option Ex 300 17.30 5,190
2017-01-04 ALKS Sale 2,500 60.01 150,017
2017-01-06 ALKS Option Ex 6,653 17.30 115,096
2017-01-05 ALKS Sale 300 60.09 18,026
2017-01-06 ALKS Sale 6,653 60.07 399,645
2016-11-10 ALKS Option Ex 5,780 17.30 99,994
2016-10-05 ALKS Option Ex 5,000 .00 0
2016-05-28 ALKS Option Ex 2,500 .00 0
2016-03-03 ALKS Option Ex 2,813 .00 0
2015-12-28 ALKS Option Ex 10,000 17.30 173,000
2015-12-28 ALKS Sale 10,000 80.24 802,390
2015-12-01 ALKS Option Ex 18,000 17.30 311,400
2015-12-01 ALKS Sale 18,000 72.89 1,311,984
2015-11-02 ALKS Sale 18,000 72.25 1,300,554
2015-11-02 ALKS Option Ex 18,000 17.30 311,400
2015-05-28 ALKS Option Ex 2,500 .00 0
2015-04-15 ALKS Option Ex 5,780 17.30 99,994
2015-03-03 ALKS Option Ex 2,812 .00 0
2014-05-28 ALKS Option Ex 2,500 .00 0
2014-01-15 ALKS Option Ex 2,780 17.30 48,094
2013-12-26 ALKS Option Ex 3,000 17.30 51,900
2012-11-13 ALKS Buy 1,200 20.13 24,156

Table 3. Insider trading of Tengion Inc (TNGN) by Stejbach Mark

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-04-09 TNGN Buy 100 5.00 500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stejbach Mark (VP & Chief Commercial Officer of Flexion Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.